نتایج جستجو برای: sledai

تعداد نتایج: 798  

2017
Michael J Boedigheimer David A Martin Zahir Amoura Jorge Sánchez-Guerrero Juanita Romero-Diaz Alan Kivitz Cynthia Aranow Tak Mao Chan Yip Boon Chong Kit Chiu Christine Wang Winnie Sohn Gregory E Arnold Michael A Damore Andrew A Welcher Barbara A Sullivan Brian L Kotzin James B Chung

OBJECTIVE To evaluate safety, pharmacokinetics and pharmacodynamics of anti-interferon (IFN)-γ monoclonal antibody AMG 811 in subjects with SLE without or with lupus nephritis (LN). METHODS In this phase Ib, randomised, multiple-dose escalation study (NCT00818948), subjects without LN were randomised to subcutaneous AMG 811 (6, 20 or 60 mg) or placebo and subjects with LN were randomised to s...

Journal: :Annals of the rheumatic diseases 2010
Jun Liang Huayong Zhang Bingzhu Hua Hong Wang Liwei Lu Songtao Shi Yayi Hou Xiaofeng Zeng Gary S Gilkeson Lingyun Sun

OBJECTIVE To determine the safety and efficacy of allogeneic mesenchymal stem cell transplantation (MSCT) in refractory systemic lupus erythematosus (SLE). METHODS A total of 15 patients with persistently active SLE underwent MSCT. Outcome was evaluated by changes in the SLE disease activity index (SLEDAI), serological features (anti-nuclear antibodies and anti-double-stranded DNA (anti-dsDNA...

2017
François Danion Laetitia Sparsa Laurent Arnaud Ghada Alsaleh François Lefebvre Vincent Gies Thierry Martin Cédric Lukas Jean Durckel Marc Ardizzone Rose-Marie Javier Jean-François Kleinmann Paul Moreau Gilles Blaison Joelle Goetz Emmanuel Chatelus Jacques-Eric Gottenberg Jean Sibilia Christelle Sordet

Background The efficacy of antitumour necrosis factor alpha (anti-TNF-α) treatment is well recognised in rheumatoid arthritis (RA) but remains controversial in systemic lupus erythematosus (SLE). Therefore, the role of anti-TNF-α treatment in 'Rhupus', a disease sharing features of RA and SLE, is still debated. Objective To evaluate the efficacy and tolerance of anti-TNF-α in patients with rh...

Journal: :The Egyptian Journal of Hospital Medicine 2021

Background: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is a multifunctional cytokine that belongs to the TNF-ligand superfamily. Objective: To evaluate ability urinary TWEAK (uTWEAK) diagnose lupus nephritis (LN) and its correlation with activity chronicity index. Patients Methods: This study was carried out on 75 individuals, 50 SLE patients, fulfilling SLICC revision ACR c...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009
Lena Schiffer Philipp Kümpers Ana M Davalos-Misslitz Marion Haubitz Hermann Haller Hans-Joachim Anders Torsten Witte Mario Schiffer

OBJECTIVES The chemokine CXCL13, also known as BCA-1 (B-cell-attracting chemokine-1) or BLC (B-lymphocyte chemoattractant), is a major regulator of B-cell trafficking. We have recently shown that excessive expression of dendritic cell-derived CXCL13 is a distinctive early event for nephritis in a murine model of systemic lupus erythematosus (SLE). Furthermore, in kidney biopsies from SLE patien...

2013
Gaetano Zizzo Justus Guerrieri Lindsay M Dittman Joan T Merrill Philip L Cohen

INTRODUCTION Systemic lupus erythematosus (SLE) is characterized by impaired efferocytosis and aberrant activation of innate immunity. We asked if shedding of MER receptor tyrosine kinase (MerTK) and AXL into soluble (s) ectodomains was related to immunological and clinical aspects of SLE. METHODS Levels of sMER and sAXL in the plasma of 107 SLE patients and 45 matched controls were measured ...

2015
Xiao Li Josh Golubovsky Joyce Hui-Yuen Ummara Shah Ewa Olech Rosalia Lomeo Vijay Singh Howard Busch Mary Jane Strandberg Kayla Strandberg Leslie Horowitz Anca Askanase Anne Eberhard Joyce Hui-Yuen Giovanni Franchin

OBJECTIVES Acthar Gel is a long-acting formulation of adrenocorticotropic hormone (ACTH) with anti-inflammatory effects thought to be mediated in part through melanocortin receptor activation. This study was initiated to understand the role of Acthar Gel in SLE treatment in rheumatology practices. METHODS This is a retrospective case series of nine adult female patients treated with Acthar Ge...

Journal: :Arthritis and Rheumatism 2007
Chee-Seng Yee Vernon Farewell David A Isenberg Anisur Rahman Lee-Suan Teh Bridget Griffiths Ian N Bruce Yasmeen Ahmad Athiveeraramapandian Prabu Mohammed Akil Neil McHugh David D'Cruz Munther A Khamashta Peter Maddison Caroline Gordon

OBJECTIVE To determine the construct and criterion validity of the British Isles Lupus Assessment Group 2004 (BILAG-2004) index for assessing disease activity in systemic lupus erythematosus (SLE). METHODS Patients with SLE were recruited into a multicenter cross-sectional study. Data on SLE disease activity (scores on the BILAG-2004 index, Classic BILAG index, and Systemic Lupus Erythematosu...

Journal: :Clinical and experimental rheumatology 2008
L Podrazilová V Peterová M Olejárová D Tegzová J Krásenský Z Seidl P Kozelek C Dostál

OBJECTIVE The aim of our study was to determine the volume of pathological foci in the brain tissue of patients suffering from systemic lupus erythematosus (SLE) with or without neuropsychiatric manifestations (NP), and also to find out if that volume depends on the study subjects' data and clinical records. Magnetic resonance (MR) scans of patients with SLE and, in particular, signs of neurops...

2016
Jill Buyon Richard Furie Chaim Putterman Rosalind Ramsey-Goldman Kenneth Kalunian Derren Barken John Conklin Thierry Dervieux

BACKGROUND The relationship between cell-bound complement activation products (CB-CAPs: EC4d, EC3d), anti-C1q, soluble complement C3/C4 and disease activity in systemic lupus erythematosus (SLE) was evaluated. METHODS Per protocol, at baseline all SLE subjects enrolled in this longitudinal study presented with active disease and elevated CB-CAPs. At each monthly visit, the non-serological (ns...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید